Repetitive drug use results in enduring structural and functional changes in the brain. Addiction research has consistently revealed significant modifications in key brain networks related to reward, habit, salience, executive function, memory and self‐regulation. Techniques like Voxel‐based Morphometry have highlighted large‐scale structural differences in grey matter across distinct groups. Source‐based Morphometry (SBM) takes this a step further by incorporating the Independent Component Analysis to detect shared patterns of grey matter variation, all without requiring prior selection of regions of interest. However, SBM has yet to be employed in the study of structural alteration patterns related to cocaine addiction. Therefore, we performed this analysis to explore alterations in structural covariance specific to cocaine addiction. Our study involved 40 individuals diagnosed with Cocaine Use Disorder (CUD) and 40 matched healthy controls. Participants with CUD completed clinical questionnaires assessing the severity of their dependence and other relevant clinical variables. Following the adjustment for age‐related effects, we observed notable disparities between groups in two structural independent components, which we identified as the structural cerebellar network and the structural lateral frontoparietal network, which display opposing trends. Specifically, the individuals with CUD exhibited a heightened contribution to the cerebellar network but simultaneously demonstrated a reduced contribution to the lateral frontoparietal network compared to the healthy controls. These findings unveil distinctive covariance patterns of neuroregulation linked with cocaine addiction, which indicates an interruption in the typical structural development in an affected lateral frontoparietal network, while suggesting an extended pattern of neuroregulation within the cerebellar network in individuals with CUD.
The reinforcement sensitivity theory (RST) proposes 3 neurobiological systems that underlie individual differences in sensitivity to reward, punishment, and motivational conflicts. From a latent variable perspective, theoretical model structures can be identified based on empirical data. We applied exploratory and confirmatory factor analyses as well as structural equation modeling (SEM) with the aim of evaluating the RST neurobiological systems from biological phenotype indicators based on brain morphological organization. We analyzed magnetic resonance imaging (MRI) data from 300 healthy adults (128 female, 172 male) using gray matter volumes extracted through the Neuromorphometrics atlas, targeting RST-related brain systems. To assess the underlying structure of RST neurobiological systems, we used principal component analysis, confirmatory factor analysis, exploratory factor analysis, and exploratory SEM, as well as its model hierarchy. All analyses were enhanced by advanced techniques such as parallel analysis and exploratory graph analysis. The findings reveal a robust 4-factor model: the behavioral activation system, the combined behavioral inhibition and fight-flight-freeze system, and a dual constraint system with dorsal cortical stream and ventral cortical stream. The dorsal cortical stream exhibited significant integrative capacity, impacting the model hierarchy through top-down projections on all the other systems. Exploratory SEM provided the best fit to the MRI data, underscoring its suitability for summarizing neural substrate data. This study provides insights into the neurobiological foundations of RST, proposing a structural brain topology that is consistent with the theoretical proposal and emerging empirical evidence in human research. The results support the integration of psychological constructs with biological phenotypes.
Background: Cognitive impairment is among the most frequently reported and disabling persistent symptoms following SARS-CoV-2 infection. Despite growing evidence of its prevalence, the characterization of domain-specific cognitive profiles and the identification of modifiable factors influencing cognitive outcomes in post-COVID-19 condition (PCC) remains scarce. Digital cognitive assessment tools have emerged as scalable and examiner-independent alternatives to traditional neuropsychological testing, but their validation in post-infectious contexts is still limited. Objective: The DigiCog study aims to characterize cognitive profiles associated with PCC, to evaluate a novel digital cognitive assessment technology (ViewMind, VMTech) against standardized neuropsychological measures, and to explore the potential role of cognitive reserve (CR) proxies in shaping cognitive outcomes following SARS-CoV-2 infection. Methods: DigiCog is a single-center cross-sectional study conducted within the Luxembourgish Predi-COVID cohort ( NCT04380987 ). Participants aged 25–65 years, with and without persistent COVID-19 symptoms, are invited to participate. Cognitive assessments are performed during face-to-face sessions by trained nurses and neuropsychologists using both the VMTech device and standardized neuropsychological tests. Additional data on PCC symptom status, CR, sociodemographic characteristics, fatigue, and psychological factors are also collected. Agreement between digital and standard cognitive assessments will be evaluated using Cohen’s kappa coefficient, with sensitivity, specificity, and receiver operating characteristic analyses as secondary measures. Cognitive performance will be compared between participants with and without PCC, and associations with CR proxies will be explored. Results: Participant recruitment began in May 2023. As of March 2025, 199 participants had been enrolled. Data collection has been completed. Data processing and statistical analyses are ongoing. Conclusions: The DigiCog study will provide new insights into cognitive functioning in PCC and evaluate the validity of a novel digital cognitive assessment approach. By integrating neuropsychological testing, digital assessment, and cognitive reserve, the study may inform scalable and more personalized approaches to cognitive screening and monitoring in post-infectious conditions. Study registration: ClinicalTrials.gov NCT06391970 ; Luxembourg National Research Ethics Committee approval No. 202208/05.